Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole

Bioorganic & Medicinal Chemistry
2015.0

Abstract

The formation of a series of analogs containing a pyridine moiety in place of the natural thiazole heterocycle, based on the potent, naturally occurring HDAC inhibitor Largazole has been accomplished. The synthetic strategy was designed modularly to access multiple inhibitors with different aryl functionalities containing both the natural depsipeptide and peptide isostere variant of the macrocycle. The cytotoxicity and biochemical activity of the library of HDAC inhibitors is described herein.

Knowledge Graph

Similar Paper

Modular synthesis and biological activity of pyridyl-based analogs of the potent Class I Histone Deacetylase Inhibitor Largazole
Bioorganic & Medicinal Chemistry 2015.0
Synthesis and Biological Characterization of the Histone Deacetylase Inhibitor Largazole and C7- Modified Analogues
Journal of Medicinal Chemistry 2010.0
Largazole Analogues Embodying Radical Changes in the Depsipeptide Ring: Development of a More Selective and Highly Potent Analogue
Journal of Medicinal Chemistry 2016.0
Synthesis and HDAC inhibitory activity of isosteric thiazoline-oxazole largazole analogs
Bioorganic & Medicinal Chemistry Letters 2013.0
Largazole and Analogues with Modified Metal-Binding Motifs Targeting Histone Deacetylases: Synthesis and Biological Evaluation
Journal of Medicinal Chemistry 2011.0
Modulation of Activity Profiles for Largazole-Based HDAC Inhibitors through Alteration of Prodrug Properties
ACS Medicinal Chemistry Letters 2014.0
Biological Evaluation of New Largazole Analogues: Alteration of Macrocyclic Scaffold with Click Chemistry
ACS Medicinal Chemistry Letters 2013.0
Synthesis and biological evaluation of largazole zinc-binding group analogs
Bioorganic & Medicinal Chemistry 2017.0
Synthesis and Antiproliferative Activity of Nitric Oxide-Donor Largazole Prodrugs
ACS Medicinal Chemistry Letters 2020.0
Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif
Bioorganic & Medicinal Chemistry 2014.0